ArticleJournal of experimental & clinical cancer research : CR2024

TRF2 as novel marker of tumor response to taxane-based therapy: from mechanistic insight to clinical implication.

Sara Iachettini et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.